SU101 small molecule inhibitor of platelet-derived growth factor: Phase II trial

By WIR Staff | Jul 20, 1998 | 7:00 AM GMT

Sugen Inc. (SUGN), Redwood City, Calif.

Read the full 65 word article

How to gain access

Continue reading with a
two-week free trial.